Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. MELICRON TABLET 80 MG [SIN11662P]

MELICRON TABLET 80 MG [SIN11662P]

Active ingredients: MELICRON TABLET 80 MG

Last updated 26 October 2025

Product Info

MELICRON TABLET 80 MG

[SIN11662P]

Product information

Active Ingredient and Strength

GLICLAZIDE - 80 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD - MALAYSIA

Registration Number

SIN11662P

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

A10BB09

Indication
Melicron is indicated for the treatment of non-insulin-dependent Diabetes Mellitus. It is used to supplement treatment by dietary modification when such modification has proved insufficient.

Dosage
In the majority of cases, 2 tablets daily (1 tablet with breakfast, 1 tablet with dinner). Dosage can vary from 1–4 tablets daily, adjusted according to the individual patient's severity of Diabetes. The usual initial dose is 40 to 80mg daily. Doses of more than 160mg should be given in 2 divided doses. Maximum dose is 320mg daily.

Contraindications
Melicron should not be used alone in insulin-dependent diabetes; juvenile-onset diabetes; diabetes complicated by ketosis and acidosis; pregnancy; diabetics undergoing surgery, after severe trauma or during infections; precoma or coma; insulin should be given together and specific care needed.
Melicron is contraindicated in patients hypersensitive to any other sulphonylureas and related drugs and patients with severe renal or hepatic insufficiency. When major surgery is to be performed, insulin therapy should be substituted for oral hypoglycaemia.